Drug intelligence / Profile preview

Thrombin-VSI

Development stage
Unknown
Lead developer
Teleflex
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Thrombin-VSI is a topical hemostatic agent containing bovine-derived thrombin (Factor IIa). It is a serine protease that facilitates the final step of the coagulation cascade by directly converting fibrinogen into fibrin, leading to the formation of a stable blood clot. This mechanism is independent of the patient's endogenous clotting factors, making it effective even in cases of impaired coagulation, provided fibrinogen is present. Developed by Vascular Solutions (now part of Teleflex), Thrombin-VSI is indicated for use in surgical procedures to control capillary and minor venular bleeding when standard techniques like ligation are ineffective. It is often supplied as a lyophilized powder to be reconstituted and applied topically, sometimes in conjunction with absorbable gelatin sponges or as part of specialized hemostatic kits like the D-Stat system. Like other bovine-derived thrombin products, its use has been associated with the development of inhibitory antibodies against bovine thrombin and Factor V, which can cross-react with human coagulation factors.

Brand names
Thrombin-VSI
Other names
Thrombin, Topical (Bovine Origin)Bovine Thrombin
02

Targets

Coagulation Factor XIIIPROC (Protein C)F5 (Coagulation Factor V)F11 (Coagulation Factor XI)F8 (Coagulation Factor VIIIa)

Beyond the preview

Go deeper on Thrombin-VSI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thrombin-VSI.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call